Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00804024 · ClinicalTrials.gov registry record
ClearWay™ RX Registry Trial
A clinical trial, sponsored by Atrium Medical Corporation.
- Completed
- Registry status
- 102
- Enrollment target
NCT00804024: Completed study, sponsored by Atrium Medical Corporation.
NCT00804024 is a clinical trial that has completed, run by Atrium Medical Corporation. The registered enrollment target is 102 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00804024 has completed, sponsored by Atrium Medical Corporation.
- COMPLETED
- Registry status
- 102 participants
- Enrollment target
Study Summary
The primary goal of this registry is to collect data regarding the use of the ClearWay RX Local Therapeutic Infusion Catheter for all indications.
Interventions
- DEVICE ClearWay™ RX Local Therapeutic Infusion Catheter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2008-08 |
| Est. Completion | 2010-10 |
What the finished NCT00804024 record still lists
NCT00804024 is an observational study that tracks outcomes without assigning an intervention. The registered 102 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which ClearWay™ RX Local Therapeutic Infusion Catheter is the first listed.
NCT00804024 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00804024 about?
NCT00804024 is a clinical study titled "ClearWay™ RX Registry Trial". The primary goal of this registry is to collect data regarding the use of the ClearWay RX Local Therapeutic Infusion Catheter for all indications.
What is the current status of trial NCT00804024?
This trial is currently completed. The enrollment target is 102 participants. The study started on 2008-08. Estimated completion is 2010-10.
What interventions are being tested in trial NCT00804024?
The interventions under investigation include: ClearWay™ RX Local Therapeutic Infusion Catheter (DEVICE).
Who is sponsoring clinical trial NCT00804024?
This trial is sponsored by Atrium Medical Corporation, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03704662 · 102 participants · NA
Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable or Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma
- NCT04174742 · 102 participants
Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer
- NCT04275362 · 102 participants
Gait Analysis of a Lateral-Pivot Design Total Knee Replacement
- NCT04541082 · 102 participants · Phase 1
Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia